
Celldex Therapeutics CLDX
$ 26.55
2.43%
Quarterly report 2025-Q3
added 11-10-2025
Celldex Therapeutics P/S Ratio 2011-2026 | CLDX
Annual P/S Ratio Celldex Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.187 | 0.338 | 0.85 | 0.286 | 0.0864 | 9.38 | 6.73 | 28.2 | 48.6 | 147 | 534 | 513 | 37.5 | 19.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 534 | 0.0864 | 96.1 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amgen
AMGN
|
4.68 | $ 348.11 | 0.97 % | $ 187 B | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
35.6 | $ 2.44 | -2.01 % | $ 137 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.96 | 0.24 % | $ 5.23 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.74 | 5.35 % | $ 9 B | ||
|
Biogen
BIIB
|
2 | $ 171.53 | -0.03 % | $ 25 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 117.74 | 1.51 % | $ 27.2 B | ||
|
BioXcel Therapeutics
BTAI
|
2.37 | $ 1.82 | - | $ 4.61 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 231.01 | -1.86 % | $ 5 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.8 | 0.46 % | $ 1.57 B | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 12.2 | -4.69 % | $ 803 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 66.74 | -0.46 % | $ 8.93 B | ||
|
Cytokinetics, Incorporated
CYTK
|
0.286 | $ 64.3 | 1.4 % | $ 7.2 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.41 | -1.34 % | $ 9.6 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.05 | -1.91 % | $ 184 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 25.84 | -0.33 % | $ 1.25 B | ||
|
Coherus BioSciences
CHRS
|
0.813 | $ 2.23 | 8.01 % | $ 210 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 13.44 | 0.34 % | $ 4.15 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 4.11 | -7.95 % | $ 116 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.7 | - | $ 17 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 94.35 | 1.51 % | $ 96.9 B |